1. Home
  2. YUMC vs ILMN Comparison

YUMC vs ILMN Comparison

Compare YUMC & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yum China Holdings Inc.

YUMC

Yum China Holdings Inc.

N/A

Current Price

$52.46

Market Cap

19.3B

ML Signal

N/A

Logo Illumina Inc.

ILMN

Illumina Inc.

N/A

Current Price

$115.47

Market Cap

20.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YUMC
ILMN
Founded
1987
1998
Country
China
United States
Employees
N/A
N/A
Industry
Restaurants
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.3B
20.4B
IPO Year
2016
2000

Fundamental Metrics

Financial Performance
Metric
YUMC
ILMN
Price
$52.46
$115.47
Analyst Decision
Hold
Analyst Count
0
17
Target Price
N/A
$124.24
AVG Volume (30 Days)
1.7M
1.9M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
2.19%
N/A
EPS Growth
7.73
170.87
EPS
2.51
5.45
Revenue
$11,797,000,000.00
$4,343,000,000.00
Revenue This Year
$9.42
$6.52
Revenue Next Year
$5.93
$5.49
P/E Ratio
$21.10
$22.26
Revenue Growth
4.37
N/A
52 Week Low
$41.00
$68.70
52 Week High
$58.39
$155.53

Technical Indicators

Market Signals
Indicator
YUMC
ILMN
Relative Strength Index (RSI) 46.41 34.71
Support Level $43.02 $114.88
Resistance Level $56.51 $135.68
Average True Range (ATR) 1.12 4.50
MACD -0.41 -0.21
Stochastic Oscillator 27.48 1.62

Price Performance

Historical Comparison
YUMC
ILMN

About YUMC Yum China Holdings Inc.

Yum China is the largest restaurant operator in China, with over 18,000 locations and USD 12 billion in systemwide sales as of 2025. It generates revenue primarily from its own restaurants and franchise fees. While KFC and Pizza Hut are its flagship brands, Yum China's portfolio also includes Little Sheep, Taco Bell, Huang Ji Huang, and Lavazza. As a trademark licensee of Yum Brands, Yum China pays 3% of KFC and Pizza Hut's systemwide sales to its former parent, from which it spun off in 2016. However, even before the separation, Yum China was granted substantial autonomy, giving its Chinese leadership decision-making authority over menu, supply chain, and marketing—an unusual practice for Western chains at the time.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: